News | Lung Imaging | October 05, 2017

Vida will combine its pulmonary imaging software suite with CompleWare’s application for clinical trial data capture and management

CompleWare and Vida Announce Joint Marketing Agreement for Respiratory Trials

October 5, 2017 — CompleWare and Vida recently announced a joint marketing agreement promoting complementary respiratory services. Their partnership will deploy a high-end pulmonary platform and excellence in clinical trial management, with precision, ISO-certified core lab imaging. 

CompleWare software and contract research organization (CRO) services will facilitate complete respiratory development programs. This will provide specialized experts to support global respiratory trials. VIDA and CompleWare will provide precision lung imaging informatics, delivered through core lab imaging services (Precision Services) and interactive software (VIDA|vision). This solution spans the care cycle, from detection through treatment across a range of pulmonary diseases: COPD (including severe emphysema, chronic bronchitis), lung cancer and asthma.

The CompleClinical application from CompleWare is a comprehensive eClinical solution for clinical trial data capture and management. The VIDA|vision pulmonary suite of software and services provides full breadth and depth of analysis, empowering chest physicians with advanced, quantitative information to help inform care decisions. 

For more information: www.compleware.com, www.vidadiagnostics.com


Additional Content

News | Stroke

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...

Time March 11, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | FDA

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Time February 26, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

Jan. 22, 2026 — Qure.ai has received a grant from the Gates Foundation to develop a large open-source multi-modal ...

Time January 23, 2026
arrow
News | Magnetic Resonance Imaging (MRI) | Children's Hospital Los Angeles

Oct. 28, 2025 — Bronchopulmonary dysplasia (BPD) is the most common — and most serious — complication of extreme ...

Time October 31, 2025
arrow
Subscribe Now